## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence presented in the abstract; no access to full manuscript, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report an in silico analysis of non-synonymous single nucleotide polymorphisms (nsSNPs) in human AIM2 and IFI16 genes, using multiple computational tools to identify deleterious variants and molecular dynamics simulations to assess structural effects. They propose that specific variants (G13V, C304R, G266R, G266D for AIM2; G13E, C356F for IFI16) are deleterious and affect structural integrity, and suggest these findings may guide future functional studies and therapeutic development.
- **Visible evidence base** Abstract text only; no methodological details, tool names, scoring thresholds, simulation parameters, or quantitative results are provided
- **Missing materials affecting confidence** Full manuscript text, all figures and tables, detailed methods for computational prediction and molecular dynamics, validation or cross-referencing data, and any statistical or convergence analyses

## Reviewer
- **Overall assessment** The abstract presents a straightforward in silico screening study with a plausible workflow, but the visible evidence is insufficient to evaluate the technical rigor or validity of the conclusions. The claims are broad relative to the evidence shown, and several key methodological details are absent. The study may be of interest to researchers in immunogenetics and structural biology, but the current abstract alone does not establish the case for the specific deleterious effects claimed.
- **Who would be interested in the results, and why** Researchers studying inflammasome biology, particularly AIM2 and IFI16 function in innate immunity, may find the identified variants useful as candidates for experimental validation. Computational biologists and structural biologists interested in nsSNP impact on protein dynamics could also be interested. However, the lack of experimental confirmation limits the immediate utility for clinical or therapeutic applications.
- **Major strengths** The study addresses a relevant topic in innate immunity, namely genetic variation in inflammasome receptors, which has potential implications for infection susceptibility and autoimmune conditions. The use of multiple computational tools and molecular dynamics simulations is a reasonable approach for prioritizing variants. The focus on structural integrity as an outcome is appropriate for the protein classes studied.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The absence of methodological detail, lack of quantitative results, and unvalidated extrapolation to therapeutic relevance are the primary technical shortcomings. Without these, the core claims cannot be assessed.
- **Assessment against Nature-style criteria** 
  - Originality: The approach is not novel, as similar in silico nsSNP analyses are common in the literature. The specific focus on AIM2 and IFI16 is a minor differentiator, but the abstract does not demonstrate conceptual innovation.
  - Scientific importance: The topic is of moderate importance, but the abstract does not provide evidence that the findings advance understanding beyond what is already known about these proteins. The clinical or functional significance of the identified variants is not established.
  - Interdisciplinary readership: The work may appeal to computational biologists and immunologists, but the abstract is too narrow and lacks broader context to attract a wide interdisciplinary audience.
  - Technical soundness: Not assessable from the abstract alone. The lack of tool names, thresholds, simulation details, and validation prevents evaluation of technical rigor.
  - Readability for nonspecialists: The abstract is concise and generally clear, but terms such as "nsSNPs," "PYD domain," and "HIN domain" are used without explanation, which may hinder nonspecialist comprehension.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially useful screening study, but the absence of methodological and quantitative details means the claims cannot be verified. A revised submission with full methods and results would be required for a supportive posture.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Technical soundness
- **Claim pointer** The authors claim that specific variants (G13V, C304R, G266R, G266D for AIM2; G13E, C356F for IFI16) are "deleterious and affect structural integrity."
- **Evidence pointer** Abstract only; location not provided
- **Concern** The abstract provides no details on which computational tools were used, what thresholds defined "deleterious," how the top variants were selected, or how molecular dynamics simulations were performed and analyzed. Without this information, the basis for the claim is unverifiable.
- **Why it matters** The core conclusion depends entirely on the computational pipeline and simulation quality. If the tools or parameters are inappropriate, or if the simulations are underpowered or not converged, the identified variants may not be genuinely deleterious. The claim cannot be accepted without transparent methods.
- **Resolution test** Provide a detailed methods section including tool names and versions, scoring criteria, variant selection thresholds, simulation software, force fields, simulation length, and convergence checks. Show quantitative results such as RMSD, RMSF, or binding energy changes that support the structural impact claims.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Scientific importance
- **Claim pointer** The authors state that the findings "may guide future research to better understand the function of these variants with large-scale studies and may assist in fresher therapeutics focusing on these polymorphisms."
- **Evidence pointer** Abstract only; location not provided
- **Concern** The abstract does not provide any evidence that the identified variants are clinically relevant, population-representative, or functionally validated. The leap from in silico prediction to therapeutic potential is unsupported.
- **Why it matters** Overstating the translational relevance of computational predictions without experimental or epidemiological support can mislead readers and overstate the study's significance. The claim of therapeutic assistance is speculative and not grounded in the presented data.
- **Resolution test** Either temper the therapeutic claim to reflect the exploratory nature of the work, or provide additional evidence such as allele frequency data, disease association, or functional assays that link the variants to biological outcomes.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Reproducibility
- **Claim pointer** The study claims to have used "different computational tools" and "molecular dynamic simulation" to reach its conclusions.
- **Evidence pointer** Abstract only; location not provided
- **Concern** No information is given on the specific tools, databases, or simulation protocols, nor on how reproducibility was ensured. The abstract does not mention any validation steps, such as cross-referencing with known disease databases or comparing with experimental structures.
- **Why it matters** Reproducibility is a cornerstone of scientific validity. Without detailed protocols, other researchers cannot replicate the study or assess its reliability. This is a fundamental requirement for any computational study.
- **Resolution test** Include a full description of all software, databases, parameters, and simulation setups, and provide access to any scripts or data used. Add validation against known variants or experimental data where possible.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Readability
- **Affected element** Abstract text
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract uses technical terms such as "nsSNPs," "PYD domain," and "HIN domain" without defining them, which may reduce accessibility for readers outside the immediate field.
- **Required correction** Briefly define these terms in the abstract or provide a short explanatory phrase to improve accessibility for a broader audience.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Clarity of claims
- **Affected element** Variant list
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract lists variants without indicating the criteria for their selection or the relative severity of their effects. It is unclear whether all listed variants are equally deleterious or if some are more impactful than others.
- **Required correction** Clarify the ranking or scoring of the variants, and specify whether the listed variants are all predicted to have similar effects or if there is a hierarchy of impact.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Contextualization
- **Affected element** Background statement
- **Evidence pointer** Abstract; location not provided
- **Issue** The abstract states that AIM2 and IFI16 are "the most studied members of AIM2-like receptors," but does not provide any citation or context for this claim, nor does it explain why these two were chosen over other ALRs.
- **Required correction** Add a brief justification for the selection of AIM2 and IFI16, and include appropriate references to support the claim of their prominence in the literature.

## Risk / unsupported claims
- The claim that the identified variants "affect structural integrity" is unsupported in the abstract, as no structural data or simulation results are shown.
- The claim that the findings "may assist in fresher therapeutics" is speculative and not supported by any evidence in the abstract.
- The general assertion that "any genetic variation in these inflammasomes can dysregulate the human immune system" is an overgeneralization that is not substantiated by the presented data.
- The selection of the specific variants as "most deleterious" is not verifiable without details on the computational tools and thresholds used.